CryoPort, Inc. (NASDAQ:CYRX) – Analysts at Zacks Investment Research raised their FY2019 EPS estimates for shares of CryoPort in a research report issued to clients and investors on Tuesday. Zacks Investment Research analyst B. Marckx now forecasts that the company will post earnings of ($0.11) per share for the year, up from their prior estimate of ($0.12).

Several other equities analysts also recently commented on CYRX. Cowen and Company upped their price objective on shares of CryoPort from $5.50 to $7.50 and gave the company an “outperform” rating in a research note on Wednesday, August 9th. Janney Montgomery Scott upped their price objective on shares of CryoPort from $8.00 to $10.00 and gave the company a “buy” rating in a research note on Wednesday, August 9th. Finally, Needham & Company LLC upped their price objective on shares of CryoPort from $6.00 to $8.50 and gave the company a “buy” rating in a research note on Wednesday, July 26th.

TRADEMARK VIOLATION NOTICE: This report was first published by Watch List News and is the sole property of of Watch List News. If you are viewing this report on another website, it was copied illegally and reposted in violation of U.S. and international copyright and trademark law. The original version of this report can be read at https://www.watchlistnews.com/zacks-investment-research-research-analysts-boost-earnings-estimates-for-cryoport-inc-cyrx/1697672.html.

CryoPort (NASDAQ CYRX) opened at $6.66 on Friday. CryoPort has a one year low of $1.96 and a one year high of $10.40.

Several large investors have recently modified their holdings of the company. Northern Trust Corp increased its position in shares of CryoPort by 105.0% during the second quarter. Northern Trust Corp now owns 22,179 shares of the company’s stock valued at $109,000 after buying an additional 11,358 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank purchased a new position in shares of CryoPort during the third quarter valued at about $118,000. BerganKDV Wealth Management LLC increased its position in shares of CryoPort by 157.5% during the second quarter. BerganKDV Wealth Management LLC now owns 25,750 shares of the company’s stock valued at $127,000 after buying an additional 15,750 shares during the period. D.A. Davidson & CO. increased its position in shares of CryoPort by 16.6% during the second quarter. D.A. Davidson & CO. now owns 137,000 shares of the company’s stock valued at $674,000 after buying an additional 19,500 shares during the period. Finally, Granite Investment Partners LLC purchased a new position in shares of CryoPort during the third quarter valued at about $535,000. 11.37% of the stock is owned by hedge funds and other institutional investors.

CryoPort Company Profile

Cryoport, Inc (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients.

Earnings History and Estimates for CryoPort (NASDAQ:CYRX)

Receive News & Ratings for CryoPort Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.